Literature DB >> 11573667

Spinal anaesthesia with ropivacaine 5 mg ml(-1) in glucose 10 mg ml(-1) or 50 mg ml(-1).

J B Whiteside1, D Burke, J A Wildsmith.   

Abstract

Forty patients undergoing spinal anaesthesia for a variety of surgical procedures were randomly allocated to receive 3 ml of ropivacaine 5 mg ml(-1) in glucose 10 mg ml(-1) or 50 mg ml(-1). Onset of sensory block to T10 was significantly faster (P=0.03) with the glucose 50 mg ml(-1) solution (median 5 min, range 2-20 min) than with the 10 mg ml(-1) solution (median 10 min, range 2-25 min). Maximum extent of cephalad spread was virtually the same in both groups (10 mg ml(-1) median T6/7, range T3-T10; 50 mg ml(-1) median T6, range T3-T10) with similar times to regression beyond S2 (10 mg ml(-1) median 210 min, range 150-330 min; 50 mg ml(-1) median 210 min, range 150-330 min). Complete motor block was produced in the majority of patients (10 mg ml(-1) 90%; 50 mg ml(-1) 85%) and the time to complete regression was the same in both groups (median 120 min, range 90-210 min). A block adequate for the projected surgery was achieved in all patients.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11573667     DOI: 10.1093/bja/86.2.241

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN: 0007-0912            Impact factor:   9.166


  15 in total

1.  The effects of intravenous dexmedetomidine on spinal hyperbaric ropivacaine anesthesia.

Authors:  Kamuran Elcicek; Murat Tekin; Ismail Kati
Journal:  J Anesth       Date:  2010-05-14       Impact factor: 2.078

2.  Dose-response study of spinal hyperbaric ropivacaine for cesarean section.

Authors:  Xin-zhong Chen; Hong Chen; Ai-fei Lou; Chang-cheng Lü
Journal:  J Zhejiang Univ Sci B       Date:  2006-12       Impact factor: 3.066

Review 3.  Regional anaesthesia in the elderly: a clinical guide.

Authors:  Ban C H Tsui; Alese Wagner; Brendan Finucane
Journal:  Drugs Aging       Date:  2004       Impact factor: 3.923

Review 4.  Benefit-risk assessment of ropivacaine in the management of postoperative pain.

Authors:  Wolfgang Zink; Bernhard M Graf
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606

5.  Comparison of two different doses of intrathecal dexmedetomidine as adjuvant with isobaric ropivacaine in lower abdominal surgery.

Authors:  Atul Kumar Singh; Yashpal Singh; Gaurav Jain; Ravi Kumar Verma
Journal:  Anesth Essays Res       Date:  2015 Sep-Dec

6.  Dose-dependent effect of intrathecal dexmedetomidine on isobaric ropivacaine in spinal anesthesia for abdominal hysterectomy: Effect on block characteristics and hemodynamics.

Authors:  Udita Naithani; Mahendra Singh Meena; Sunanda Gupta; Khemraj Meena; Lalatendu Swain; D S Pradeep
Journal:  J Anaesthesiol Clin Pharmacol       Date:  2015 Jan-Mar

7.  Effects of intrathecal hyperbaric ropivacaine versus hyperbaric bupivacaine for lower limb orthopedic surgery.

Authors:  Somjit Chatterjee; Bikash Bisui; Anamitra Mandal; Jagabandhu Sheet; Swapnadeep Sengupta; Shakya Majumdar; Sarbari Swaika
Journal:  Anesth Essays Res       Date:  2014 Sep-Dec

8.  A comparative evaluation of hyperbaric ropivacaine versus hyperbaric bupivacaine for elective surgery under spinal anesthesia.

Authors:  Kalpana R Kulkarni; Sunetra Deshpande; Ismail Namazi; Sunil Kumar Singh; Konark Kondilya
Journal:  J Anaesthesiol Clin Pharmacol       Date:  2014-04

9.  Hyperbaric spinal ropivacaine in lower limb and hip surgery: A comparison with hyperbaric bupivacaine.

Authors:  Feroz Ahmad Dar; Mohsin Bin Mushtaq; Umar Mushtaq Khan
Journal:  J Anaesthesiol Clin Pharmacol       Date:  2015 Oct-Dec

10.  Comparison between intrathecal isobaric ropivacaine-fentanyl and bupivacaine-fentanyl in elective infraumbilical orthopedic surgery: A randomized controlled study.

Authors:  Amitava Layek; Souvik Maitra; Nitish K Gozi; Sulagna Bhattacharjee; Sugata Pal; Suvadeep Sen; Avijit Hazra
Journal:  J Anaesthesiol Clin Pharmacol       Date:  2015 Oct-Dec
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.